Pharmafile Logo

ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement

November 26, 2025 | ESMO 2025, Scientific Engagement 

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.

- PMLiVE

At this year’s European Society for Medical Oncology (ESMO) Congress, the spotlight wasn’t only on data, it was on design. Across the exhibition floor, exhibitors reimagined how science could be experienced, not just explained. 

Inizio experts Ellen Maxwell (Scientific Strategy Director, Ashfield MedComms, Inizio Medical), Stephanie Tortell (President, Ashfield MedComms, Inizio Medical) and Katie Streten (Head of Creative Strategy, Emota) observed a clear shift: from communication to connection, from presentation to participation.   

Designing for engagement: Turning booths into scientific experiences 

From booth layouts to interactive displays, design took center stage at ESMO – not as decoration, but as a driver of understanding. 

“The most compelling booths weren’t the flashiest,” Ellen noted, “Every interactive element, from digital journeys to hands-on models, served a clear purpose: to make science tangible.” 

Stephanie added, “And that purpose extended to design strategy itself. Visibility, flow, and comfort were treated as integral to storytelling. When you design around how people move, think, and feel, the experience becomes effortless and unforgettable.” 

Together, they noted how thoughtful design turned passive observation into active understanding, signaling a new era of scientific engagement. 

Using emotion to enhance scientific storytelling and engagement 

Beyond form and function, exhibitors tapped into feeling – recognizing that emotion can make scientific stories unforgettable. 

“We’re seeing science expressed with emotional intelligence,” Katie reflected. “Visuals, color, and motion now work together to create moments of feeling as much as fact.” 

Ellen agreed, “And accessibility is part of that emotion. In busy congress spaces, subtitled visuals and clean motion graphics ensure everyone can engage, no matter the noise or language barriers.” 

Their shared insight: the most effective storytelling isn’t about spectacle, but rather about empathy, clarity, and connection. 

Visual identity at ESMO 2025: Confidence through color and form 

That emotional energy extended to the visual identity of the congress itself, where confidence and clarity shone through in every detail. 

“There’s been a definite shift in aesthetic tone,” Stephanie observed. “We’ve moved from softness to strength, and from subtle graphics to confident, assertive visuals that reflect precision and purpose.” 

Katie continued, “That confidence shows in color too. Pharma brands are embracing vibrant hues and distinctive identities. But the best examples used color with intention instead of just decoration in order to amplify the story, not distract from it.” 

This balance of creativity and credibility defined the visual language of ESMO 2025. 

Sustainable design in scientific exhibits: ESMO 2025 trends 

Alongside creativity came conscience. Sustainability was no longer a differentiator, but a shared expectation.  

Ellen observed, “Sustainability has matured beyond messaging. Reusable materials, modular builds, and transparent environmental commitments are now baseline expectations.” 

Stephanie agreed, adding, “And that’s inspiring. It shows how creativity and responsibility don’t have to simply coexist but actually reinforce each other. Conscious design isn’t a constraint; it’s a catalyst for smarter solutions.” 

Together, they reflected on how environmental awareness is reshaping the aesthetics and ethics of scientific spaces. 

Human-centered design: Creating meaningful congress experiences 

And at the heart of it all was the human experience – because even in data-driven spaces, connection is what people remember. 

Katie reflected, “Comfort remains the quiet driver of engagement. A seat, a drink, or a place to pause are the moments that turn interaction into conversation.” 

Stephanie added, “Exactly. Hospitality is about creating calm within the chaos. When people feel cared for, they’re more open, more curious, and more present.” 

In a setting driven by data, these human touches remind us that empathy is still science’s most powerful connector. 

From information to inspiration: Redefining scientific engagement 

Across ESMO 2025, one message rang clear: connection is the new currency of communication. Science alone informs, but science paired with design, emotion, and sustainability inspires. 

As Ellen, Stephanie, and Katie each observed, the future of congress engagement lies in integration and blending creativity and clarity to make every interaction meaningful. 

At Inizio, we believe this is where innovation truly happens: when stories of science become experiences that stay with people long after they leave the floor. 

For a complementary perspective on the scientific and strategic trends shaping oncology, explore ESMO 2025 Insights: Emerging Oncology Trends Highlighting the Need for Precision Medical Affairs by Rüdiger Papsch, Partner, Medical & Scientific Affairs, Inizio Advisory. 

And for a deeper look into the creative shifts redefining experiential design at pharma congresses, take a look at Four Creative Shifts from ESMO: What’s Next for Experiential Design in Pharma by Katie Streten, Head of Creative Strategy at Emota (part of Inizio Engage). 

Ready to elevate your congress presence?  

Let’s talk about transforming science into story. Learn more about our full-service congress solution, or contact us today. 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Pegasus expands Pharma team with senior hires

Five new recruits support further growth of the Pharma & Life Sciences team

Webcast: Poker face revealed: Using facial analysis to uncover deeper levels of emotional insight

In the first part of our series covering market research innovations which have value in healthcare, we demonstrate how we've been using facial analysis to delve further into respondents' reactions...

Report: Living with RA (EU, Japan and Canada) 2019 reports

Research Partnership launches new patient Living with  Rheumatoid Arthritis (EU & Japan)  2019 report.r Living with Rheumatoid Arthritis (RA) is a quantitative study conducted online amongst 390 patients diagnosed with RA in...

News: Therapy Watch launches a new wave of EU tracking in Psoriasis (PsO)

A panel of 40 dermatologists in each of the major EU markets reports on patients on advanced therapies including biologics and small molecule therapies every quarter. In addition from Q1...

Emerging Markets: Your Essential Guide

Using our combined knowledge and years of experience of working in these territories our emerging markets experts have produced this essential guide to help address some of the core challenges...

Live webinar: Navigating new frontiers: Ways to find space in the future RA market

In partnership with pharmaphorumThursday 21st March 201915:00 GMT / 16:00 CETRegister now to secure your place »The emergence of low-cost biosimilar versions of Humira and the new janus kinase (JAK) inhibitors,...

New appointments in our UK and New York offices

Research Partnership is delighted to announce various appointments across our offices. Ella Buckland joins as Research Executive, Ines Belchior joins as Research Analyst, and Emma Warburton joins as Business Development...

Pharma Market Research Conference NJ, 2019

We are delighted to be presenting and exhibiting at PMRC, 6-7 February in Newark, NJ.Representing Research Partnership at the conference will be New York-based Directors Liza Pliss and Mariana Servin.Liza...

Research Partnership ranks 13th in the top 20 fastest-growing agencies in the UK

The UK’s best performing market research agencies were revealed earlier this month with the publication of Research Live’s Industry Report for 2019, which includes the latest Market Research Society (MRS)...